At a glance
- Probiotics and prebiotics for the gut-brain axis in patients with IBS
- BiCT develops and validates the formulations on advanced preclinical models
- Experimental groundwork for the clinical studies that follow
Project Description
PRO-MIND addresses one of the most promising fields of contemporary biomedical research: the close interaction between the gastrointestinal tract and the central nervous system, commonly known as the gut-brain axis.The project aims to develop innovative probiotic and prebiotic therapies designed to support psychological well-being in patients suffering from chronic gastrointestinal disorders, particularly Irritable Bowel Syndrome (IBS). The initiative is driven by the growing recognition that conventional pharmacological treatments, although widely prescribed, often present important limitations, including adverse effects and substantial economic burden. To overcome these challenges, the PRO-MIND consortium is developing natural, evidence-based therapeutic solutions based on optimized probiotic strains capable of simultaneously targeting gut health and depressive symptoms.
BiCT contributes its expertise in biotechnology by supporting the development and preclinical validation of these formulations using advanced experimental models, paving the way for future clinical studies. PRO-MIND represents a valuable example of translational innovation, bridging cutting-edge scientific research with real-world healthcare applications to improve patients' quality of life while reducing the social and economic burden associated with mental health disorders.
Funding Programme
The project is funded by the Lombardy Region under the 2021–2027 ERDF Regional Programme (European Regional Development Fund), Priority 1 – "A More Competitive and Smarter Europe", Action 1.1.3 – "Support for the implementation of complex research, development and innovation projects", within the Collabora & Innova Call.Effect of Probiotics on Depressive Symptoms in Patients with Disorders of Gut-Brain Interaction: A Comparative Study of Probiotics versus Placebo
Project Objective
The PRO-MIND project was established to investigate the relationship between the gut microbiota and mental well-being, with the aim of developing innovative probiotic therapies for patients affected by disorders of the gut-brain axis, particularly Irritable Bowel Syndrome (IBS) associated with depressive symptoms.The project seeks to reduce reliance on conventional antidepressant medications, which are often associated with significant side effects and high healthcare costs, by promoting a natural, safe, and sustainable approach based on optimized probiotic formulations capable of improving both intestinal health and mental well-being.







